Get started
Author

Neha Bhatia

Observed institution: Central University of Punjab
ORCID: 0000-0002-0416-8543
Observed ORCID: 0000-0002-0416-8543
OpenAlex ID: A5042716222
Elacestrant: a new FDA-approved SERD for the treatment of breast cancer
2023 · Neha Bhatia, Suresh Thareja · Medical Oncology · 25
Recent Advancements in the Discovery of MDM2/MDM2-p53 Interaction Inhibitors for the Treatment of Cancer
2022 · Neha Bhatia, Rakesh Khator, et al. · Current Medicinal Chemistry · 18
Molecular docking, 3D-QSAR and simulation studies for identifying pharmacophoric features of indole derivatives as 17β-hydroxysteroid dehydrogenase type 5 (17β-HSD5) inhibitors
2023 · Swanand Kulkarni, Yogesh Singh, et al. · Journal of Biomolecular Structure and Dynamics · 14
Medicinal Aspects of PTP1B Inhibitors as Anti-Breast Cancer Agents: An Overview
2023 · Rakesh Khator, Avadh Biharee, et al. · Current Medicinal Chemistry · 11
Developing our knowledge of the quinolone scaffold and its value to anticancer drug design
2023 · Yogesh Singh, Neha Bhatia, et al. · Expert Opinion on Drug Discovery · 11
Simulation, 3D-QSAR, molecular docking and pharmacophore mapping studies on indole derivatives as aromatase inhibitors
2025 · Neha Bhatia, Suresh Thareja · Letters in Drug Design & Discovery · 5
Optimizing selective estrogen receptor degraders for anticancer drug development
2025 · Neha Bhatia, Shashank Kumar, et al. · Future Medicinal Chemistry · 2
Knoevenagel Condensation through Greener Synthesis: An Overview
2026 · Suresh Thareja, Dheeraj Kumar Choudhary, et al. · Current Organic Chemistry
Inavolisib-based Combination Therapy for the Treatment of PIK3CAMutated HR+/HER2- Breast Cancer: An Overview
2026 · Sushmita Bhatia, Neha Bhatia, et al. · Mini-Reviews in Medicinal Chemistry
Protacs Targeting ERα in the Effective Management of Endocrinal Resistance Breast Cancer
2025 · Anupriya Singh, Roshni Khan, et al. · Archiv der Pharmazie
In silico-assisted prediction of chemoresistance
2025 · Neha Bhatia, Khushi Gupta, et al. · Elsevier eBooks
Gaussian-based 3D-QSAR and Pharmacophore Mapping Studies of Indole Derivatives as Aromatase Inhibitors
2025 · Neha Bhatia, Suresh Thareja · Anti-Cancer Agents in Medicinal Chemistry
Works count: 12
Citation count: 86
H-index: 5
I10-index: 5
Year
Topic
Type